Diseases of complement dysregulation-an overview.

about

Introduction to complement in health and disease: novel aspects and insights.Short- and Long-Term Renal Outcome of Hemolytic-Uremic Syndrome in Childhood

P2860

Q50128144-9745785C-F979-4AB4-83A7-CCB11510A04C Q58797348-CBE615F1-C7B1-4A0E-8CEC-5B3D344CBF8A

P2860

Diseases of complement dysregulation-an overview.

Item

http://www.wikidata.org/entity/Q48256943

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Diseases of complement dysregulation-an overview.

@en

Diseases of complement dysregulation-an overview.

@nl

type

Item

label

Diseases of complement dysregulation-an overview.

@en

Diseases of complement dysregulation-an overview.

@nl

prefLabel

Diseases of complement dysregulation-an overview.

@en

Diseases of complement dysregulation-an overview.

@nl

P1476

Diseases of complement dysregulation-an overview.

@en

P2093

Edwin K S Wong

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

PIG-S and PIG-T, essential for GPI anchor attachment to proteins, form a complex with GAA1 and GPI8

Deletion of Lys224 in regulatory domain 4 of Factor H reveals a novel pathomechanism for dense deposit disease (MPGN II)

Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome

Structural basis for engagement by complement factor H of C3b on a self surface

Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype

Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis

Eculizumab for dense deposit disease and C3 glomerulonephritis

Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome

Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease)

Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome

P2888

s00281-017-0663-8

P304

49-64

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1007/S00281-017-0663-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

David Kavanagh

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2018-01-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29327071

http://www.w3.org/2001/XMLSchema#string

P921

blood proteins

P932

5794843

http://www.w3.org/2001/XMLSchema#string

Diseases of complement dysregulation-an overview.

about

P2860

P2860

Diseases of complement dysregulation-an overview.

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932